Your dose may increase over time, but your price stays the same
Read more obesity medicine news: Subscribe to my free newsletter: All my links: If you found this helpful, please Like, Subscribe, and Share this episode with someone navigating obesity, diabetes, or GLP-1 treatment
Excessive glutamate in the PFC and striatum has also been linked to withdrawal symptoms (Hinton et al., 2012
GLP-1 RA use in this population was associated with improved QOL across physical health-, mental health-, diabetes-, and weight-related domains, as well as improvements in eating restraint and emotional eating
Observed risks include malnutrition, specifically thiamine deficiency, metabolic acidosis, and hypomagnesemia
Varela A et al